Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 325
Selected: 0
NCT IDTitle
NCT02801526Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
NCT05897216Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029
NCT01682564To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure
NCT05741437A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378
NCT02498509Clinical Trial to Evaluate the Efficacy and Safety of CKD-342
NCT05526703Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
NCT04703374A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
NCT04221360A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375
NCT01270984Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects
NCT03067415Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
NCT05245084A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
NCT05544214Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
NCT03848637The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375
NCT03849495Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults
NCT05189288Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects
NCT02631954Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers
NCT05843162A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
NCT02358824CKD-828 (80/5mg) Pharmacokinetic Study
NCT07770737Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes
NCT01029522Dyslipidemia in Cardiovascular Disease
NCT05050604A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients
NCT01630018Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
NCT01766518The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)
NCT01663038Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination
NCT03017950Pharmacokinetic Drug-drug Interaction of CKD-330 and D086
NCT03211143A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects
NCT03175835Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT04478097Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
NCT02159976Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
NCT03739125Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
NCT03627182Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes
NCT02854748Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin
NCT02064621CKD-330 Drug-Drug Interaction Study (Candesartan)
NCT06399068Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions
NCT02565368A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers
NCT05657574A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia
NCT04706286Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393
NCT02066207CKD-337 Drug Interaction Study
NCT05587699The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
NCT04555434Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH
NCT02588937Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients
NCT02300467NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
NCT02356679Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
NCT04805606A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843
NCT04676893Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects
NCT03849287Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults
NCT04906785Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
NCT03887858Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers
NCT02422030CKD-337(2) Drug-drug Interaction Study
NCT01022671Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy